Natural Health Trend (NHTC)
Official siteCONSUMER CYCLICAL • INTERNET RETAIL • NASDAQ
Market Cap: $6.33M
Last updated: Nov 17, 2026 at 11:03 AM ET
Natural Health Trend (NHTC) Financials: Revenue, Profit and Cash Flow
Natural Health Trend reported revenue of $39.78M for the fiscal year ended Dec 31, 2025, down 7.4% from the year before. That year, net income was -$882.00K with a net margin of -2.2%, operating cash flow was -$6.00M and free cash flow was -$6.07M. The quarter ended Sep 30, 2026 had revenue of $7.56M and net income of -$232.00K.
Revenue and Margins
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $39.78M | -7.4% | 73.5% | -4.5% | -2.2% |
| Dec 2024 | $42.96M | -2.2% | 74.0% | -3.0% | 1.3% |
| Dec 2023 | $43.92M | -10.6% | 74.6% | -3.8% | 1.3% |
| Dec 2022 | $49.13M | -18.1% | 74.2% | -0.5% | 0.6% |
| Dec 2021 | $60.01M | -3.3% | 75.0% | 2.6% | 1.8% |
| Dec 2020 | $62.07M | -20.0% | 72.6% | 1.1% | 1.4% |
| Dec 2019 | $77.61M | -59.6% | 74.1% | -9.0% | -7.2% |
| Dec 2018 | $191.91M | -2.9% | 79.5% | 17.6% | 16.2% |
| Dec 2017 | $197.56M | N/A | 80.4% | 21.8% | 11.9% |
| Sep 2017 | $12.09B | N/A | 49.1% | 12.2% | 9.1% |
Income Statement
In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Sep 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.78M | $42.96M | $43.92M | $49.13M | $60.01M | $62.07M | $77.61M | $191.91M | $197.56M | $12.09B |
| Cost of revenue | $10.52M | $11.18M | $11.18M | $12.66M | $15.01M | $16.99M | $20.10M | $39.37M | $38.65M | $6.15B |
| Gross profit | $29.25M | $31.79M | $32.75M | $36.47M | $44.99M | $45.08M | $57.51M | $152.54M | $158.92M | $5.94B |
| Research and development | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $774.00M |
| Operating income | -$1.81M | -$1.30M | -$1.67M | -$270.00K | $1.57M | $669.00K | -$7.02M | $33.73M | $43.06M | $1.48B |
| Net income | -$882.00K | $572.00K | $568.00K | $313.00K | $1.08M | $843.00K | -$5.61M | $31.04M | $23.58M | $1.10B |
| EBITDA | -$458.00K | $751.00K | $909.00K | $806.00K | $1.81M | $1.90M | -$5.21M | $34.95M | $43.96M | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.56M | $7.60M | $9.21M | $9.75M | $9.48M | $9.81M | $10.74M | $10.85M | $10.69M | $10.47M | $10.95M | $10.94M |
| Gross profit | $5.61M | $5.72M | $6.90M | $7.11M | $6.99M | $7.25M | $7.91M | $8.04M | $7.93M | $7.78M | $8.04M | $8.15M |
| Operating income | -$277.00K | -$643.00K | -$474.00K | -$635.00K | -$495.00K | -$333.00K | -$345.00K | -$421.00K | -$275.00K | -$238.00K | -$365.00K | -$242.00K |
| Net income | -$232.00K | -$451.00K | -$154.00K | -$588.00K | -$431.00K | $15.00K | $122.00K | $176.00K | $35.00K | $173.00K | $188.00K | $358.00K |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $869.00K by $5.94M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Sep 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $38.43M | $55.36M | $69.09M | $82.82M | $98.36M | $105.94M | $118.50M | $157.92M | $159.55M | $37.73B |
| Current assets | $34.19M | $50.98M | $64.23M | $77.55M | $93.47M | $99.74M | $108.38M | $150.19M | $151.24M | $18.63B |
| Cash and equivalents | $6.81M | $13.53M | $56.18M | $69.67M | $83.84M | $92.37M | $96.03M | $132.65M | $135.31M | $14.18B |
| Total liabilities | $15.00M | $22.49M | $27.49M | $32.67M | $38.87M | $38.24M | $43.43M | $68.06M | $68.93M | $24.79B |
| Short-term debt | $869.00K | $1.13M | $1.15M | $1.14M | $1.24M | $1.16M | $1.66M | $18.91M | $19.08M | $203.00M |
| Long-term debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $18.67B |
| Shareholder equity | $23.43M | $32.87M | $41.60M | $50.15M | $59.49M | $67.70M | $75.06M | $89.86M | $90.62M | $12.95B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $27.26M | $29.21M | $31.95M | $38.43M | $42.25M | $45.16M | $53.18M | $55.36M | $58.29M | $61.49M | $67.64M | $69.09M |
| Total liabilities | $12.26M | $14.01M | $15.49M | $15.00M | $16.10M | $16.31M | $22.30M | $22.49M | $22.99M | $24.24M | $28.27M | $27.49M |
| Cash and equivalents | $5.82M | $9.50M | $9.22M | $6.81M | $14.34M | $10.53M | $21.69M | $13.53M | $22.90M | $15.58M | $25.82M | $56.18M |
| Shareholder equity | $15.00M | $15.20M | $16.46M | $23.43M | $26.15M | $28.86M | $30.88M | $32.87M | $35.30M | $37.25M | $39.37M | $41.60M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Sep 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$6.00M | -$3.37M | -$4.28M | -$4.85M | $1.02M | $1.89M | -$18.64M | $29.71M | $26.61M | $2.55B |
| Capital expenditures | $68.00K | $57.00K | $46.00K | $143.00K | $225.00K | $211.00K | $189.00K | $214.00K | $278.00K | $727.00M |
| Free cash flow | -$6.07M | -$3.42M | -$4.32M | -$5.00M | $791.00K | $1.67M | -$18.83M | $29.50M | $26.33M | $1.82B |
| Dividends paid | $9.21M | $9.21M | $9.21M | $9.14M | $9.14M | $9.14M | $7.34M | $31.51M | $17.22M | $677.00M |
| Share repurchases | N/A | N/A | N/A | N/A | N/A | N/A | $10.12M | $0 | N/A | N/A |
| Investing cash flow | $8.15M | -$30.07M | -$46.00K | -$143.00K | -$225.00K | -$211.00K | -$189.00K | -$214.00K | -$278.00K | -$883.00M |
| Financing cash flow | -$9.21M | -$9.21M | -$9.21M | -$9.14M | -$9.14M | -$9.14M | -$17.46M | -$31.51M | -$17.22M | $10.98B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.09M | -$1.36M | -$797.00K | -$959.00K | $113.00K | -$5.63M | $484.00K | $88.00K | -$436.00K | -$3.57M | $549.00K | -$69.00K |
| Capital expenditures | $7.00K | $325.00K | $115.00K | $5.00K | $43.00K | $4.00K | $16.00K | $20.00K | $7.00K | $19.00K | $11.00K | $14.00K |
| Free cash flow | -$1.10M | -$1.69M | -$912.00K | -$964.00K | $70.00K | -$5.64M | $468.00K | $68.00K | -$443.00K | -$3.59M | $538.00K | -$83.00K |
Frequently Asked Questions About NHTC
What is Natural Health Trend's annual revenue?
Natural Health Trend reported revenue of $39.78M for the fiscal year ended Dec 31, 2025.
How fast is Natural Health Trend's revenue growing?
Revenue was down 7.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -6.8%.
Is Natural Health Trend profitable?
No. Natural Health Trend reported net income of -$882.00K for the fiscal year ended Dec 31, 2025, with a net margin of -2.2%.
How much free cash flow does NHTC generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$6.00M minus capital expenditures of $68.00K produced free cash flow of -$6.07M.
How much debt does Natural Health Trend have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $869.00K and cash and equivalents of $6.81M.
NHTC pages: Overview, Dividends, Financials, Valuation, Competitors